HCPCS code J9029: Adstiladrin, per therapeutic dose2026 Medicare rate & RVUs

Nadofaragene firadenovec is a bladder-instilled gene therapy reported per therapeutic dose for adults with certain high-risk, BCG-unresponsive bladder cancer.

CMS RVU26DEffective Oct 1, 2026109 payment localities

Medicare rate · J9029

Adstiladrin, per therapeutic dose

Office or facility?

Work RVUs
0
Total RVUs
0.00
Global days
XXX

National rate · 2026

—

Not priced in the facility setting.

See every locality for J9029 →Billed by an NP, PA or therapist? →

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

Your location

Medicare pays by the payment locality where the service is performed.

On this page 10 sections
  1. Medicare rate
  2. What J9029 covers
  3. By payment locality
  4. Rate map
  5. How it’s calculated
  6. Payment rules
  7. Similar codes
  8. Related codes
  9. Billing questions
  10. Sources

What J9029 covers

J9029 identifies nadofaragene firadenovec-vncg, marketed as Adstiladrin, for delivery into the bladder through a urinary catheter. Urologists typically administer it in an outpatient setting for adults with high-risk, BCG-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ, with or without papillary tumors. It is a local bladder treatment, not an intravenous or intramuscular injection.

Report one unit for each therapeutic dose administered; the unit is not a milliliter or a count of viral particles. CMS excludes J9029 from the physician fee schedule under status E. CMS classifies it as a Part B drug, generally priced from quarterly Average Sales Price files when covered. Coverage is left to the Medicare contractor’s judgment.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where J9029 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

J9029 office and facility rates by payment locality
Payment localityOfficeFacility
AlabamaUnavailableUnavailable
AlaskaUnavailableUnavailable
ArizonaUnavailableUnavailable
ArkansasUnavailableUnavailable
Atlanta, GAUnavailableUnavailable
Austin, TXUnavailableUnavailable
Bakersfield, CAUnavailableUnavailable
Baltimore area, MDUnavailableUnavailable
Beaumont, TXUnavailableUnavailable
Brazoria, TXUnavailableUnavailable

J9029 rates by state

Office rate range in each state. Select a state to see its payment localities.

Explore a state

Local rates. Clear comparisons.

Hover or focus a tile to see its rate range. Select it to open the state’s fee schedule.

View every state and territory as a table
J9029 office rate range by state
State / territoryOffice rate rangeLocalities
AKNo published base rate1
ALNo published base rate1
ARNo published base rate1
AZNo published base rate1
CANo published base rate29
CONo published base rate1
CTNo published base rate1
DCNo published base rate1
DENo published base rate1
FLNo published base rate3
GANo published base rate2
GUNo published base rate1
HINo published base rate1
IANo published base rate1
IDNo published base rate1
ILNo published base rate4
INNo published base rate1
KSNo published base rate1
KYNo published base rate1
LANo published base rate2
MANo published base rate2
MDNo published base rate3
MENo published base rate2
MINo published base rate2
MNNo published base rate1
MONo published base rate3
MSNo published base rate1
MTNo published base rate1
NCNo published base rate1
NDNo published base rate1
NENo published base rate1
NHNo published base rate1
NJNo published base rate2
NMNo published base rate1
NVNo published base rate1
NYNo published base rate5
OHNo published base rate1
OKNo published base rate1
ORNo published base rate2
PANo published base rate2
PRNo published base rate1
RINo published base rate1
SCNo published base rate1
SDNo published base rate1
TNNo published base rate1
TXNo published base rate8
UTNo published base rate1
VANo published base rate2
VINo published base rate1
VTNo published base rate1
WANo published base rate2
WINo published base rate1
WVNo published base rate1
WYNo published base rate1

How the J9029 rate is calculated

Each of J9029’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

How the rate is built · J9029

RVUs × geographic indexes × conversion factor

Office or facility?

Work0.00

0.00 RVUs× 1.000 GPCI

Practice expense0.00

0.00 RVUs× 1.000 GPCI

Malpractice0.00

0.00 RVUs× 1.000 GPCI

Adjusted RVUs

0.0000

Conversion factor

$33.4009

Medicare rate

$0.00

Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.

Payment rules and modifiers for J9029

J9029 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

Place of service · J9029

Which rate does Medicare pay?

The POS code on the claim line (CMS-1500 box 24B).

POS 11 · non-facility rate · national

—

J9029 isn’t priced in this setting.

J9029 compared with similar codes

Compare codes · National

J9029 vs J9030 vs 51720: Medicare rates

Office or facility?

  • J9029

    Adstiladrin, per therapeutic dose0 wRVU

    Not priced

  • J9030

    Intravesical BCG, per 1 mg0 wRVU

    Not priced

  • 51720

    Bladder instillation, antineoplastic agent0.85 wRVU

    $91.85

How to choose

J9030Intravesical BCGPer 1 mg
J9030 reports live intravesical BCG per milligram. J9029 reports nadofaragene firadenovec per therapeutic dose.
51720Bladder instillationAntineoplastic agent
CPT 51720 describes the bladder instillation procedure; J9029 identifies the nadofaragene firadenovec drug dose.

J9029 billing questions

What does one unit of J9029 represent?

One unit represents one therapeutic dose of nadofaragene firadenovec. Do not calculate units from the instilled volume or viral-particle count.

Is J9029 the drug or the bladder-instilling service?

J9029 identifies the drug per therapeutic dose. CPT 51720 describes the bladder instillation service and may be reported for the administration when applicable.

How does Medicare treat J9029?

CMS assigns status E, excluding the code from the physician fee schedule. When covered, it is treated as a Part B drug and generally priced using CMS quarterly ASP files.

Does Medicare coverage follow automatically from the code?

No. Coverage is left to the Medicare contractor’s judgment.

How is J9029 different from J9030?

J9029 is nadofaragene firadenovec gene therapy per therapeutic dose. J9030 identifies intravesical live BCG per milligram, a different bladder treatment.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates

Did this answer your question about what J9029 pays?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put J9029 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist